促红细胞生成素导致肥胖小鼠棕色脂肪PPAR &gamma;、UCP1和&beta;3-AR的表达变化

苗莹莹; 鲁明; 赵俊强

doi:10.13418/j.issn.1001-165x.2017.06.011

中国临床解剖学杂志 ›› 2017, Vol. 35 ›› Issue (6) : 645-649. DOI: 10.13418/j.issn.1001-165x.2017.06.011

实验研究

促红细胞生成素导致肥胖小鼠棕色脂肪PPAR γ、UCP1和β3-AR的表达变化

苗莹莹¹，　鲁明¹，　赵俊强²

作者信息 +

Changes of PPAR γ, UCP1 and β3-AR mRNA expression of HFD-induced mice with EPO injection

MIAO Ying-ying¹, LU Ming¹, ZHAO Jun-qiang²

Author information +

文章历史 +

摘要

目的　观察注射促红细胞生成素（Erythropoietin，EPO）后，高脂喂养（high fat diet, HFD）的肥胖小鼠模型体重、脂肪含量变化以及白色脂肪组织、棕色脂肪组织中过氧化物酶体增殖激活受体γ（peroxisome proliferator-activated receptor γ，PPAR γ）、解偶联蛋白1（uncoupling protein 1，UCP1）、β3肾上腺素能受体（β3 adrenoceptor, β3-AR）mRNA以及蛋白的表达变化，为EPO治疗肥胖的机制提供线索。方法　20只高脂喂养的C57BL/6J雄鼠随机分为对照组（HFD-Con）和EPO组（HFD-EPO）。4周后比较两组动物的体重，实时定量PCR方法检测皮下脂肪、附睾脂肪以及棕色脂肪中的PPAR γ、UCP1和β3-AR mRNA表达变化。结果　4周后，与对照组比较，EPO组体重（24.53±2.03）g，HFD-Con组体重为（31.78±1.68）g，P<0.001。HFD-EPO组动物的皮下脂肪与附睾脂肪重量均显著减少，P<0.001。HE染色结果显示，相较于HFD-Con组，HFD-EPO组动物的脂肪细胞减小。半定量PCR和Western blotting结果显示，皮下脂肪组织与附睾脂肪组织中的PPAR γ、UCP1、β3-AR mRNA以及蛋白的表达均无显著性改变，而棕色脂肪中的PPAR γ、UCP1、β3-AR的mRNA以及蛋白表达均显著增加。结论　棕色脂肪中PPARγ、UCP1、β3-AR表达变化可能与高脂喂养后注射EPO导致体重减轻存在一定的联系。

Abstract

Objective　Erythropoietin (EPO) has been reported to have a beneficial effect on obesity. The aim of the study is to investigate the changes of body weight and fat content of EPO in high fat diet (HFD) mice, the expression of PPAR γ, UCP1, β3-AR mRNA in white adipose tissue (WAT) and brown adipose tissue (BAT). Methods 20 HFD-fed C57BL/6J male mice were randomly divided into control group (HFD-Con) and EPO group (HFD-EPO). The expression of PPAR γ, UCP1 and β3-AR mRNA in subcutaneous fat, epididymal fat and brown fat were detected by real-time quantitative RT-PCR. Results Compared with the control group, the body weight of the EPO mice was (24.53±2.03) g and the control group was (31.78±1.68) g. The weight of subcutaneous fat and epididymal fat in HFD-EPO group were significantly decreased. HE staining showed that the size of adipocytes of HFD-EPO group was decreased compared with HFD-Con group. Quantitative real-time PCR results showed that the expression of PPAR γ, UCP1 and β3-AR mRNA in subcutaneous adipose tissue and epididymal adipose tissue did not change significantly, while the expression of PPAR γ, UCP1 and β3-AR in brown fat were significantly increased. Conclusion　The expression of PPAR γ, UCP1 and β3-AR in brown fat may be related to the weight loss caused by EPO injection after high fat diet.

导出引用

苗莹莹,鲁明,赵俊强. 促红细胞生成素导致肥胖小鼠棕色脂肪PPAR γ、UCP1和β3-AR的表达变化[J]. 中国临床解剖学杂志. 2017, 35(6): 645-649 https://doi.org/10.13418/j.issn.1001-165x.2017.06.011

MIAO Ying-ying, LU Ming, ZHAO Jun-qiang. Changes of PPAR γ, UCP1 and β3-AR mRNA expression of HFD-induced mice with EPO injection[J]. Chinese Journal of Clinical Anatomy. 2017, 35(6): 645-649 https://doi.org/10.13418/j.issn.1001-165x.2017.06.011

参考文献

[1] van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men [J]. N Engl J Med, 2009, 360 (15):1500-1508.
[2] Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults [J]. N Engl J Med, 2009, 360(15):1518-1525.
[3] Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans [J]. N Engl J Med, 2009, 360(15):1509-1517.
[4] Cazzola M. How and when to use erythropoietin [J]. Curr Opin Hematol, 1998, 5(2):103-108.
[5] Katz O, Stuible M, Golishevski N, et al. Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models [J]. J Endocrinol, 2010, 205(1):87-95.
[6] Teng R, Gavrilova O, Suzuki N, et al. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production [J]. Nat Commun, 2011, 2:520.
[7] Kotanko P, Thijssen S, Levin NW. Association between erythropoietin responsiveness and body com- position in dialysis patients [J]. Blood Purif, 2008, 26(1):82-89.
[8] Townsend KL, Tseng YH. Of mice and men: novel insights regarding constitutive and recruitable brown adipocytes [J]. Int J Obes Suppl, 2015, 5(Suppl 1):S15-20.
[9] Lee YH, Jung YS, Choi D. Recent advance in brown adipose physiology and its therapeutic potential [J]. Exp Mol Med, 2014, 46:e78.
[10] Saito M. Human brown adipose tissue: regulation and anti-obesity potential [J]. Endocr J, 2014, 61(5):409-416.
[11] Liu Y, Luo B, Shi R, et al. Nonerythropoietic erythropoietin-derived peptide sup-presses adipogenesis, inflammation, obesity and insulin resistance [J]. Sci Rep, 2015, 5:15134.
[12] Alnaeeli M, Raaka BM, Gavrilova O, et al. Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity [J]. Diabetes, 2014, 63(7):2415-2531.
[13] Christensen B, Nellemann B, Jorgensen JO, et al. Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo [J]. Lipids Health Dis, 2016, 15(1):160.
[14] Hu E, Kim JB, Sarraf P, et al. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma [J]. Science, 1996, 274(5295):2100-2103.
[15] Sugimoto S, Nakajima H, Kodo K, et al. Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice [J]. Nutr Metab (Lond), 2014 , 11(1):14.
[16] Sell H, Deshaies Y, Richard D. The brown adipocyte: update on its metabolic role [J]. Int J Biochem Cell Biol, 2004, 36(11):2098-2104.